Pharmacologic evaluation of delayed long-acting cabotegravir administration among cisgender women in HPTN 084.
Mark A MarzinkeKelong HanBrett HanscomXu GuoEstelle Piwowar-ManningCraig W HendrixScott RoseElizabeth SpoonerCarrie MathewSteven InnesRogers SekabiraMercy MutambanengweJames F RooneyAlex R RinehartAdeola AdeyeyeMyron S CohenMina HosseinipourSusan L FordSinead Delany-MoretlwePublished in: Antimicrobial agents and chemotherapy (2024)
This study is registered with ClinicalTrials.gov as NCT03164564.